MediPal Holdings Corporation - Income Statement (TTM)

MediPal Holdings Corporation
US ˙ OTCPK ˙ JP3268950007

Income Statement (TTM)

MediPal Holdings Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 3,186,651 3,208,237 3,211,125 3,241,838 3,265,951 3,279,583 3,290,921 3,304,372 3,333,073 3,351,069 3,360,008 3,408,417 3,453,601 3,507,505 3,558,732 3,581,312 3,604,415 3,650,989 3,671,328 3,707,170
Change (%) 0.68 0.09 0.96 0.74 0.42 0.35 0.41 0.87 0.54 0.27 1.44 1.33 1.56 1.46 0.63 0.65 1.29 0.56 0.98
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,962,305 2,988,885 2,996,864 3,026,850 3,049,926 3,062,688 3,073,476 3,085,957 3,112,923 3,127,503 3,135,703 3,180,801 3,219,471 3,267,232 3,312,077 3,331,395 3,352,694 3,396,779 3,415,569 3,449,332
Change (%) 0.90 0.27 1.00 0.76 0.42 0.35 0.41 0.87 0.47 0.26 1.44 1.22 1.48 1.37 0.58 0.64 1.31 0.55 0.99
% of Revenue 92.96 93.16 93.33 93.37 93.39 93.39 93.39 93.39 93.39 93.33 93.32 93.32 93.22 93.15 93.07 93.02 93.02 93.04 93.03 93.04
Gross Operating Profit 224,346 219,352 214,261 214,988 216,025 216,895 217,445 218,415 220,150 223,566 224,305 227,616 234,130 240,273 246,655 249,917 251,721 254,210 255,759 257,838
Change (%) -2.23 -2.32 0.34 0.48 0.40 0.25 0.45 0.79 1.55 0.33 1.48 2.86 2.62 2.66 1.32 0.72 0.99 0.61 0.81
% of Revenue 7.04 6.84 6.67 6.63 6.61 6.61 6.61 6.61 6.61 6.67 6.68 6.68 6.78 6.85 6.93 6.98 6.98 6.96 6.97 6.96
SG&A 168,472 166,875 162,908 160,995 158,634 158,300 159,487 160,279 161,021 165,230 163,143 167,292 177,341 178,360 185,673 188,012 184,083 185,136 186,634 187,938
Change (%) -0.95 -2.38 -1.17 -1.47 -0.21 0.75 0.50 0.46 2.61 -1.26 2.54 6.01 0.57 4.10 1.26 -2.09 0.57 0.81 0.70
% of Revenue 5.29 5.20 5.07 4.97 4.86 4.83 4.85 4.85 4.83 4.93 4.86 4.91 5.13 5.09 5.22 5.25 5.11 5.07 5.08 5.07
R&D
Change (%)
% of Revenue
OpEx 3,143,484 3,168,531 3,172,547 3,200,509 3,221,098 3,233,423 3,245,296 3,258,513 3,286,183 3,304,943 3,311,034 3,360,558 3,409,540 3,458,848 3,511,397 3,533,095 3,550,552 3,595,494 3,615,717 3,650,789
Change (%) 0.80 0.13 0.88 0.64 0.38 0.37 0.41 0.85 0.57 0.18 1.50 1.46 1.45 1.52 0.62 0.49 1.27 0.56 0.97
% of Revenue 98.65 98.76 98.80 98.73 98.63 98.59 98.61 98.61 98.59 98.62 98.54 98.60 98.72 98.61 98.67 98.65 98.51 98.48 98.49 98.48
Operating Income 43,167 39,706 38,578 41,329 44,853 46,160 45,625 45,859 46,890 46,126 48,974 47,859 44,061 48,657 47,335 48,217 53,863 55,495 55,611 56,381
Change (%) -8.02 -2.84 7.13 8.53 2.91 -1.16 0.51 2.25 -1.63 6.17 -2.28 -7.94 10.43 -2.72 1.86 11.71 3.03 0.21 1.38
% of Revenue 1.35 1.24 1.20 1.27 1.37 1.41 1.39 1.39 1.41 1.38 1.46 1.40 1.28 1.39 1.33 1.35 1.49 1.52 1.51 1.52
Interest Expense -101 -72 -50 -36 -25 -22 -16 -15 -13 -23 -34 -33 -32 -20 -8 -7 -7 -7 -7 -9
Change (%) -28.71 -30.56 -28.00 -30.56 -12.00 -27.27 -6.25 -13.33 76.92 47.83 -2.94 -3.03 -37.50 -60.00 -12.50 -0.00 -0.00 -0.00 28.57
% of Revenue -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Net Income 33,329 26,682 23,926 26,468 30,523 36,411 29,423 28,248 28,222 30,439 38,806 41,724 38,636 37,244 41,474 39,294 46,047 49,426 40,279 40,857
Change (%) -19.94 -10.33 10.62 15.32 19.29 -19.19 -3.99 -0.09 7.86 27.49 7.52 -7.40 -3.60 11.36 -5.26 17.19 7.34 -18.51 1.43
% of Revenue 1.05 0.83 0.75 0.82 0.93 1.11 0.89 0.85 0.85 0.91 1.15 1.22 1.12 1.06 1.17 1.10 1.28 1.35 1.10 1.10

Source: Capital IQ

Other Listings
DE:59Z €15.30
JP:7459 ¥2,685.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista